JPMA Voices Major Disappointment with TRIPS Waiver Pact

June 21, 2022
The Japan Pharmaceutical Manufacturers Association (JPMA) issued a statement on June 20 expressing a deep disappointment with a decision made at a World Trade Organization ministerial meeting last week to waive intellectual property protections for COVID-19 vaccines. “We are deeply...read more